News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
46,849 Results
Type
Article (1885)
Company Profile (5)
Press Release (44959)
Section
Business (21516)
Career Advice (54)
Deals (3358)
Drug Delivery (9)
Drug Development (5534)
Employer Resources (8)
FDA (991)
Job Trends (1379)
News (28092)
Policy (1431)
Tag
2027 Genetown Digital (1)
2027 NextGen (1)
Academia (134)
Accelerated approval (7)
ADA (2)
Adcomms (1)
Allergies (18)
Alliances (1259)
ALS (14)
Alzheimer's disease (123)
Antibody-drug conjugate (ADC) (71)
Approvals (1108)
Artificial intelligence (39)
ASCO (41)
Autoimmune disease (34)
Automation (3)
Bankruptcy (6)
Belgium (3)
Best Places to Work (1264)
BIO (2)
Biosimilars (20)
Biotechnology (1)
Bladder cancer (31)
Brain cancer (6)
Breast cancer (129)
Cancer (791)
Cardiovascular disease (44)
Career advice (54)
Career pathing (8)
CAR-T (25)
CDC (1)
CDMO (10)
Celiac Disease (3)
Cell therapy (59)
Cervical cancer (6)
Clinical research (5686)
Collaboration (104)
Commercialization (3)
Compensation (97)
Complete response letters (2)
COVID-19 (169)
CRISPR (10)
C-suite (33)
Cystic fibrosis (7)
Data (1179)
Depression (13)
Dermatology (16)
Diabetes (75)
Diagnostics (572)
Digital health (8)
Diversity, equity & inclusion (1)
Drug discovery (17)
Drug pricing (8)
Drug shortages (1)
Duchenne muscular dystrophy (29)
Earnings (20254)
Editorial (3)
Employer resources (9)
Events (4307)
Executive appointments (28)
Eye disease (1)
FDA (1553)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (105)
Gene editing (17)
Generative AI (4)
Gene therapy (33)
GLP-1 (137)
Government (204)
Grass and pollen (1)
Guidances (218)
Healthcare (1461)
Hematology (21)
HIV (20)
Huntington's disease (8)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (14)
Immunology and inflammation (40)
Immuno-oncology (7)
Indications (33)
Infectious disease (204)
Inflammatory bowel disease (28)
Influenza (12)
Intellectual property (13)
Interviews (8)
IPO (2715)
IRA (4)
Job creations (158)
Job search strategy (37)
JPM (4)
Kidney cancer (2)
Kidney disease (19)
Labor market (18)
Layoffs (55)
Leadership (2)
Legal (173)
Licensing (2)
Liver cancer (11)
Lung cancer (133)
Lymphoma (100)
Machine learning (1)
Management (3)
Manufacturing (61)
Marketing (2)
MASH (36)
Medical device (1163)
Medtech (1185)
Mergers & acquisitions (743)
Metabolic disorders (193)
mRNA (18)
Multiple sclerosis (15)
NASH (2)
Netherlands (1)
Neurodegenerative disease (34)
Neuropsychiatric disorders (9)
Neuroscience (247)
NextGen: Class of 2026 (359)
Non-profit (276)
Now hiring (5)
Obesity (80)
Opinion (8)
Ovarian cancer (31)
Pain (27)
Pancreatic cancer (35)
Parkinson's disease (14)
Patents (27)
Patient recruitment (28)
Patient selection (6)
Peanut (4)
People (1093)
Peptides (2)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase 1 (1090)
Phase 2 (2251)
Phase 3 (2730)
Pipeline (2247)
Policy (18)
Postmarket research (242)
Preclinical (295)
Press Release (7)
Prostate cancer (45)
Psychedelics (4)
Radiopharmaceuticals (18)
Rare diseases (115)
Real estate (185)
Recruiting (6)
Regenerative medicine (2)
Regulatory (1563)
Reports (13)
Research institute (102)
Resumes & cover letters (5)
Rett syndrome (2)
RSV (8)
Schizophrenia (30)
Series A (17)
Series B (11)
Service/supplier (1)
Sickle cell disease (15)
Special edition (2)
Spinal muscular atrophy (11)
Sponsored (1)
Startups (92)
Stomach cancer (5)
Supply chain (6)
Tariffs (3)
The Weekly (5)
Vaccines (84)
Venture capital (7)
Weight loss (61)
Wet AMD (1)
Women's health (17)
Worklife (6)
Date
Today (6)
Last 7 days (53)
Last 30 days (183)
Last 365 days (3375)
2026 (2435)
2025 (3467)
2024 (3460)
2023 (3664)
2022 (4358)
2021 (4251)
2020 (3908)
2019 (3264)
2018 (2443)
2017 (2008)
2016 (1524)
2015 (1919)
2014 (1226)
2013 (731)
2012 (1109)
2011 (1159)
2010 (937)
Location
Africa (47)
Alabama (8)
Arizona (29)
Asia (2609)
Australia (272)
California (1633)
Canada (412)
China (139)
Colorado (59)
Connecticut (70)
Delaware (96)
Europe (6808)
Florida (215)
Georgia (57)
Hawaii (1)
Idaho (1)
Illinois (141)
India (10)
Indiana (112)
Iowa (1)
Japan (71)
Kansas (14)
Kentucky (6)
Louisiana (18)
Maine (13)
Maryland (157)
Massachusetts (1059)
Michigan (38)
Minnesota (93)
Missouri (25)
Montana (1)
Nebraska (1)
Nevada (18)
New Hampshire (8)
New Jersey (642)
New Mexico (1)
New York (402)
North Carolina (203)
North Dakota (2)
Northern California (875)
Ohio (42)
Pennsylvania (321)
Puerto Rico (1)
Rhode Island (2)
South America (61)
South Carolina (2)
Southern California (670)
Tennessee (22)
Texas (201)
United States (5779)
Utah (84)
Virginia (25)
Washington D.C. (6)
Washington State (138)
Wisconsin (15)
Wyoming (1)
46,849 Results for "37".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 37, 2026)
September 14, 2026
·
3 min read
Press Releases
IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2026
September 14, 2026
·
1 min read
Press Releases
37 Kaiser Permanente hospitals recognized by U.S. News & World Report
August 4, 2026
·
3 min read
Press Releases
Altay Therapeutics Closes $37 Million Series A Financing to Advance First Oral DUX4 Inhibitor for FSHD into the Clinic
October 14, 2026
·
4 min read
Press Releases
MustGrow Closes $3.7 Million Non-Brokered LIFE Offering
June 19, 2026
·
6 min read
Press Releases
37th International Symposium on Human Identification (ISHI) Highlights Impact of Forensic DNA Science on Real Casework Examples
August 18, 2026
·
3 min read
Press Releases
ReEmerge, Inc. Exits Stealth with Oversubscribed $37M Series A to Challenge the Limitations of Chronic Cognitive Impairment Caused by Brain Injuries
September 15, 2026
·
5 min read
Press Releases
MustGrow Increases Non-Brokered LIFE Offering to Approximately $3.7 Million
June 18, 2026
·
6 min read
Press Releases
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
July 31, 2026
·
12 min read
Press Releases
Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity
August 5, 2026
·
16 min read
1 of 4,685
Next
